Study Complete
Sponsor ID
20090176
Preference Between Two Autoinjectors in Patients with Rheumatoid Arthritis and Plaque Psoriasis Treated with Etanercept
Study Details
The study will estimate the preference of rheumatoid arthritis (RA) and Plaque Psoriasis (PsO) patients who self inject etanercept for one of two experimental autoinjectors.
Protocol Summary
Primary Outcome Measures
Preference for autoinjector A versus autoinjector B assessed by the Subject Preference Questionnaire administered after the completion of the 2 treatment periods at week 8.
Timeframe: At week 8
Secondary Outcome Measures
Using the Subject’s Perception of Self-injecting Questionnaire the following secondary endpoint will be evaluated at baseline and at week 4 prior to training with the autoinjector
Timeframe: At baseline and Week 4
Using the Subject’s Experience with the Autoinjector Questionnaire, the following secondary endpoints will be evaluated after the completion of each 4-week treatment period
Timeframe: At week 4 and week 8
Certainty of completing the injection with the autoinjector
Timeframe: At week 4 and week 8
Convenience
Timeframe: At week 4 and week 8
Discomfort
Timeframe: At week 4 and week 8
Satisfaction
Timeframe: at week 4 and week 8
Pain associated with use of the autoinjector
Timeframe: At week 4 and week 8
Study Documents
Study Synopsis
Available Language(s): English
Locations
Location
Research Site
Austin, TX, United States, 78731
Status
Recruiting
Location
Research Site
Barrie, ON, Canada, L4M 7G1
Status
Recruiting
Location
Research Site
Bismarck, ND, United States, 58502
Status
Recruiting
Location
Research Site
Charleston, SC, United States, 29414
Status
Recruiting
Location
Research Site
Clarksburg, WV, United States, 26301
Status
Recruiting
Location
Research Site
Courtice, ON, Canada, L1E 3C3
Status
Recruiting
Showing {first} - {last} of {total} Results